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E2F Repression by C/EBP Is Required for
Adipogenesis and Granulopoiesis In Vivo
cell types investigated and cannot be overcome by mu-
tations affecting the Rb or p53 pathways, nor by SV40
large T antigen (Hendricks-Taylor and Darlington, 1995;
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1Laboratory of Gene Therapy Research Muller et al., 1999; Umek et al., 1991). In liver tissue
growth inhibition by C/EBP has been proposed to be2 Institute of Pathology
3 Department of Clinical Biochemistry due to its ability to increase levels of the p21 cyclin-
dependent kinase inhibitor (p21cdki; Park et al., 2000;Copenhagen University Hospital
2100 Copenhagen Ø Timchenko et al., 1997), and expression of p21cdki from
a hepatocyte-specific promoter in transgenic mice hasDenmark
shown that p21cdki is indeed capable of blocking hepa-
tocyte proliferation during liver regeneration (Wu et al.,
1996). However, the lack of proliferation defects inSummary
p21cdki knockout mice (Deng et al., 1995) and the ability
of C/EBP to arrest cell proliferation in the absence ofThe C/EBP transcription factor is required for differ-
entiation of adipocytes and neutrophil granulocytes, p21cdki (Muller et al., 1999), indicates that other mecha-
nisms are involved in C/EBP-mediated growth arrest.and controls cellular proliferation in vivo. To address
the molecular mechanisms of C/EBP action, we have A recent report has demonstrated direct repression of
E2F-dependent transcription by C/EBP (Slomiany etidentified C/EBP mutants defective in repression of
E2F-dependent transcription and found them to be al., 2000), and Johansen et al. (Johansen et al., 2001)
have found c-Myc expression in myeloid cells to beimpaired in their ability to suppress cellular prolifera-
tion, and to induce adipocyte differentiation in vitro. repressed by C/EBP through an E2F binding site in the
c-myc promoter. Altogether, these results show thatUsing targeted mutagenesis of the mouse germline,
we show that E2F repression-deficient C/EBP alleles C/EBP can control multiple pathways of growth inhibi-
tion, and indicate that C/EBP downregulates the ex-failed to support adipocyte and granulocyte differenti-
ation in vivo. These results indicate that E2F repression pression of genes that maintain cells in an undifferenti-
ated and proliferative state through E2F repression.by C/EBP is critical for its ability to induce terminal
differentiation, and thus provide genetic evidence that To address its role in the control of cellular prolifera-
tion and differentiation, we determined the moleculardirect cell cycle control by a mammalian lineage-
instructive transcription factor couples cellular growth requirements for C/EBP-mediated E2F repression. We
found the N-terminal part of the C/EBP transactivationarrest and differentiation.
domain and residues residing on the non-DNA binding
face of the C/EBP basic region to be required forIntroduction
growth suppression, inhibition of E2F1/DP1-mediated
transcription, and adipogenesis mediated by C/EBP.The C/EBP family of basic region-leucine zipper tran-
scription factors plays an important role in the growth Consistent with E2F repression being a required func-
tion for C/EBP during adipocyte differentiation, ectopicand differentiation of many tissues and cell types in vivo.
The analysis of knockout mice has shown that C/EBP, E2F1 expression in 3T3-L1 preadipocytes blocked their
C/EBP-dependent in vitro differentiation. Introductionthe founding member of the C/EBP family, is necessary
for energy homeostasis. C/EBP null mice die from hy- of E2F repression-defective C/EBP alleles into the
mouse germline resulted in severe defects in adipocytepoglycemia within a few hours after birth (Wang et al.,
1995b) and have reduced expression of liver-specific and granulocyte differentiation, while liver development,
gene expression, and glycogen synthesis remained nor-genes involved in glucose metabolism and glycogen
synthesis, including glycogen synthase (GS), phospho- mal. These results indicate that C/EBP-mediated E2F
repression is generally required for C/EBP-dependentenolpyruvate carboxykinase (PEPCK) and glucose-6-
phosphatase (G6Pase). Also, the differentiation of white differentiation processes in vivo.
adipose tissue is strongly impaired (Wang et al., 1995b),
and C/EBP knockout mice completely lack both neu- Results
trophil and eosinophil granulocytes (Zhang et al., 1997).
In addition to its role in normal granulocyte develop- C/EBP TE-I Is Required for C/EBP-Mediated
ment C/EBP has recently been charaterized as a tumor Adipocyte Differentiation, Growth Suppression
suppressor gene in acute myeloid leukemias (Pabst et and E2F Inhibition
al., 2001), indicating an important role for this transcrip- Transduction of NIH3T3 fibroblasts with a C/EBP en-
tion factor in the control of cellular proliferation in vivo. coding retrovirus leads to the formation of mature adipo-
Consistent with this, defects observed in liver and lung cytes, expressing both early and late adipocyte markers,
tissues of C/EBP null mice appear to relate to the ability without induction of the endogenous C/EBP gene. This
of C/EBP to arrest cellular proliferation (Flodby et al., allows mutant versions of the C/EBP protein to be
1996). This capacity of C/EBP is universal among the tested for their ability to induce adipocyte differentiation
without interference from endogenous C/EBP. We
have previously defined three transactivation elements,4 Correpondence: nerlov@embl-monterotondo.it
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TE-I through -III, in the C/EBP transactivation domain
(Nerlov and Ziff, 1994). We transduced NIH3T3 fibro-
blasts with pBabePuro retrovirus encoding wild-type
C/EBP or C/EBP derivatives lacking each individual
TE, as well as a C/EBP mutant lacking the putative
C/EBP GSK3 and PKC phosphorylation sites (D200-
256; Ross et al., 1999) (Figure 1A). Adipogenesis was
severely impaired in the absence of TE-I or TE-III, as
observed by morphology (Figure 1B) and quantitative
Oil Red O staining (Figure 1C), despite expression of the
mutant proteins at the same level as wild-type C/EBP
(Figure 1D), indicating that these two domains mediate
nonredundant functions during adipocyte differentia-
tion. In contrast, TE-II and amino acids 200-256 were not
essential for C/EBP-mediated adipogenesis in vitro.
In order to correlate the ability of C/EBP to induce
adipocyte differentiation to its capacity to repress cell
proliferation, we used a modification of the selection
scheme devised by Umek et al. (1991). We transduced
NIH3T3 cells with retrovirus encoding fusions of the vari-
ous C/EBP derivatives to EGFP and selected for the
retroviral construct under conditions of exponential
growth. This results in high expression of those C/EBP
alleles that have little growth inhibitory potential, and
low expression of those that strongly suppress growth.
This can be quantified by determination of EGFP levels
using flow cytometry. NIH3T3 cells were infected with
pBabePuro-based retrovirus encoding the C/EBP-
EGFP fusion proteins and allowed to proliferate under
puromycin selection for approximately 15 population
doublings. Importantly, the EGFP fluorescence was
maintained throughout the cell populations, showing
that loss of expression of the C/EBP-EGFP fusion pro-
teins did not occur (Figure 2A). Flow cytometry showed
that expression of the C/EBP D1-70-EGFP fusion was
uniformly and significantly (Figures 2A and 2B) increased
compared to the wild-type C/EBP-EGFP fusion in pro-
liferating populations, whereas a modest increase was
observed for the other three deletion mutants (Figure 2B).
We analyzed several potential mechanisms for
C/EBP-mediated growth inhibition, such as pRb inter-
action, p21cdki interaction and E2F repression. Of these
Figure 1. C/EBP Functions Required for Adipogenesisonly E2F inhibition showed any correlation to the growth
inhibitory potential of the C/EBP derivatives (Figures (A) Structure of the C/EBP protein. The positions of the three trans-
activation elements (TEs), putative phosphorylation sites for GSK32C and 2D and data not shown). Transient transfection
and PKC, and the basic region-leucine zipper (BR-LZ) are indicated.experiments indicated a greater than 10-fold decrease
(B) Morphology of NIH3T3 cultures transduced with empty pBabe-in the ability of C/EBP D1-70 to repress E2F1/DP1-
Puro derived retrovirus (vector) or pBabePuro encoding the indi-mediated transcription compared to wild-type C/EBP.
cated C/EBP derivatives after 2 weeks of puromycin selection.
The other deletion mutants showed an approximately Adipocytes appear opaque in phase contrast microscopy.
2-fold decrease in repression, correlating with the (C) Quantification of adipocyte differentiation induced by C/EBP
growth suppression analysis. In contrast, no good corre- proteins. The cultures parallel to those above were fixed, stained
with Oil Red O, and the dye bound to triglycerides, extracted, andlation between pRb interaction and growth suppression
quantified. Each datapoint represents the average of two triplicateor adipogenesis was observed (Figure 2D). Most signifi-
determinations after subtraction of the value obtained with pBabe-cantly, deletion of TE-II had the strongest effect on the
Puro alone. Error bars indicate standard deviations.C/EBP-pRb interaction, but did not detectably affect
(D) Equal amounts of total cellular protein from NIH3T3 cultures
adipocyte differentiation (Figure 1C). These results thus from (B) were subjected to Western blotting with C103 polyclonal
indicated that loss of ability to repress E2F1/DP1-medi- anti-C/EBP antiserum. The positions of the 42 and 30 kDa C/EBP
ated transcription strongly impaired the ability of forms are indicated.
C/EBP to induce adipocyte differentiation, and sug-
gested that the nonredundant function of TE-III was
sibility that TE-I mediates other unique functions thatunrelated to E2F inhibition. Indeed, we have found that
could account for its inability to induce adipogenesisthe essential TE-III function is recruitment of the SWI/
led us to search for additional C/EBPmutants defectiveSNF chromatin remodeling complex (T.A˚., E. Kowenz-
Leutz, A. Leutz, and C.N., submitted). However, the pos- in E2F inhibition.
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Conserved Non-DNA Binding Residues in the
C/EBP Basic Region Are Required for E2F
Repression and Adipogenesis
We systematically analyzed the basic region-leucine
zipper domain for residues required for E2F repression.
Replacement of the C/EBP leucine zipper with the
GCN4 leucine zipper had no effect on repression of
E2F1/DP1-mediated transcription (data not shown). We
next mutated basic region residues which, based on
molecular modeling of the C/EBP protein on crystal
structures of the related c-Fos, c-Jun, and GCN4 pro-
teins, are predicted to reside on the non-DNA binding
face of the basic region  helix (BRM1, -2, and -3; Figure
3B) or are located beyond the residues involved in DNA
contact in known bZIP structures, but highly and specifi-
cally conserved in C/EBP proteins (BRM5; Figure 3A).
Of these mutants BRM2 and BRM5, but not BRM1 or
BRM3, were impaired in their ability to repress E2F1/
DP1-dependent transcription (Figure 3C). The same two
mutants were found to have a significantly decreased
ability to suppress growth (both comparable to the TE-I
deletion mutant; Figure 3D). Finally, while all of the
C/EBPmutant proteins showed the same nuclear local-
ization (by immunofluorescence microscopy) and in vitro
DNA binding (by gel retardation analysis) as wild-type
C/EBP (data not shown; see below Figure 5E), both
C/EBP BRM2 and BRM5 were strongly impaired in
their capacity to promote adipogenesis as measured
by triglyceride accumulation (Figure 3E), and to induce
expression of adipocyte-specific genes, such as PPAR
and aP2 (data not shown), after transduction into NIH3T3
adipocytes. These results were consistent with repres-
sion of E2F activity by C/EBP being a requirement
during adipocyte differentiation.
Ectopic E2F1 Activity Blocks Adipogenesis In Vitro
To further address this question, the 3T3-L1 preadipo-
cyte cell line, which can be hormonally induced to un-
dergo C/EBP-dependent adipocyte differentiation (Lin
and Lane, 1992), was transduced with pBabePuro-
based retrovirus encoding a fusion between the tamoxi-
fen-specific estrogen receptor hormone binding domain
age of three independent determinations after subtraction of the
autofluorescence of vector transduced cells. Error bars indicate
standard deviations.
(C) Q2bn fibroblasts were transfected with the E2F-responsive E2F6-
TATA-LUC reporter and pRSV-Gal internal control plasmid (100 ng
each). pCMV-E2F1 and pCMV-DP1 (5 ng each) was added and CMV-
C/EBP expression vectors (10, 30, and 100 ng, increasing left to
right) were included as indicated. pCMVneoBam (for E2F1/DP1) and
pcDNAI (for C/EBP derivatives) control vectors were added to
maintain identical DNA concentrations. After 48 hr luciferase and
-galactosidase activities were measured, and their ratio (after sub-
traction of the mock transfected background values) calculated for
each construct combination. Each value represents the average of
Figure 2. Correlation between Growth Inhibition and E2F Repres- four such determinations. Error bars indicate standard deviations.
sion by C/EBP (D) The interaction of the indicated C/EBP derivatives with the pRb
(A) The EGFP fluorescence of NIH3T3 cultures transduced with pocket domain was analyzed by in vitro pull down. The amount of
pBabePuro (control), pBabePuro-C/EBP (WT) and pBabePuro-C/ GST-Rb bound C/EBP (after subtraction of the background ob-
EBPD1-70 (D1-70) was determined by flow cytometry after 2 weeks tained with GST alone) was quantified for each allele and is shown
of subconfluent culture (approximately 15 cell divisions). relative to the value obtained with wild-type C/EBP (of which about
(B) The mean EGFP fluorescence of cultures (treated as in A) con- 10% of the input was bound). The values shown represent the aver-
taining the indicated C/EBP-EGFP fusions. Each value is the aver- age of three determinations; error bars indicate standard deviations.
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Figure 3. C/EBP Basic Region Residues Required for E2F Repression
(A) Alignment of the c-Fos, cJun, GCN4, and C/EBP basic regions. For the former three, the residues implicated in DNA binding by X-ray
crystallography (Protein Data Bank accession no. 1FOS and 1YSA) are indicated below the sequence. Those positions where one or two
amino acid residues account for all four proteins are shown as a consensus sequence. The positions of the basic region mutations introduced
into C/EBP are indicated below the C/EBP sequence.
(B) The positions of the mutated residues in C/EBP are highlighted on the c-Fos crystal structure: BRM-1: red; BRM-2: yellow; BRM-3: blue;
BRM-5: orange.
(C) Repression of E2F1/DP1 by the C/EBP basic region mutants was analyzed as in Figure 2C.
(D) Expression of C/EBP-EGFP fusions containing the indicated basic region mutations in proliferating NIH3T3 cultures were determined as
in Figure 2B.
(E) Induction of adipocyte differentiation by C/EBP BRM alleles was determined as in Figures 1B and 1C.
and the E2F1 protein (ERTME2F1 WT), the same fusion ished, whereas the pBabePuro transduced control cells
and those expressing ERTME2F1 E132 differentiated nor-containing a disabling point mutation in the E2F1 DNA
binding domain (ERTME2F1 E132), or the empty control mally, as judged by cellular morphology (Figure 4A) and
expression of aP2 mRNA (Figure 4B), demonstrating thatvector (pBabePuro). This fusion between E2F1 and the
estrogen receptor is strictly dependent on 4-hydroxy- deregulated E2F activity is incompatible with adipocyte
differentiation mediated by C/EBP. The inability of thetamoxifen (4OHT) for its ability to induce expression of
E2F target genes (Vigo et al., 1999). In the absence of E2F1 DNA binding mutant to block differentiation, de-
spite it being expressed at a level identical to that of4OHT all transduced cell populations underwent adi-
pose conversion to the same extent upon hormonal in- the wild-type protein (Figure 4C), further indicates that
binding of E2F1 to target promoters is required for itsduction (data not shown). However, if differentiation was
induced in the presence of 4OHT, differentiation of the ability to block adipocyte differentiation. These results
thus fully supported the notion that repression of E2F-ERTME2F1 WT transduced cells was essentially abol-
E2F Repression by C/EBP In Vivo
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combination in embryonic stem (ES) cells, using the
targeting strategy outlined in Figure 5A. In addition to
generating a control knockin of the wild-type C/EBP
sequence (WTKI), we introduced the BRM2 and BRM5
E2F repression-deficient alleles, and the putative hyper-
morphic BRM1 allele. In all cases the neomycin selection
cassette was flanked by loxP sites, enabling its removal
through Cre-mediated recombination. However, we
found no abnormalities in the WTKI mice in the presence
of the neo marker (see below), and analysis of the
knockin strains was therefore performed without delet-
ing the cassette. Henceforth the true wild-type C/EBP
allele will be designated “,” the wild-type control
knockin “WT,” the BRM1 knockin allele “1n,” etc. In
contrast to the C/EBP knockout mice, homozygotes
of all of the knockin alleles survived birth, although lower
than Mendelian ratios of the 2n/2n and 5n/5n genotypes
were observed at the adult stages (8 weeks) at which
they were analyzed. The C/EBP knockout mice die
perinatally from hypoglycemia, most likely caused by
inability to synthesize glycogen, and newborns have
reduced levels of GS, G6Pase and PEPCK mRNA (Wang
et al., 1995b). The absolute requirement for C/EBP for
PEPCK expression is consistent with C/EBP being the
most active C/EBP isoform in PEPCK promoter activa-
tion (Crosson and Roesler, 2000). Postnatally, the ex-
pression of these genes is also strictly dependent on
C/EBP, as Cre-mediated deletion of the C/EBP locus
in the adult liver leads to a 90% reduction of both
PEPCK and GS mRNA (Lee et al., 1997). Consistent with
the viability of homozygous knockin mice, we observed
no change in the abundance of PEPCK mRNA in any of
the genotypes (Figure 5B), and livers from mice of all
lines showed similar accumulation of glycogen in vessel
Figure 4. E2F1 Blocks Adipocyte Differentiation flanking hepatocytes (Figure 5D). Consistent with this,
(A) 3T3-L1 pradipocytes were transduced with pBabePuro (vector) microarray-based comparison of liver RNA from /,
and pBabePuro-based retrovirus encoding fusions of wild-type 2n/2n and 5n/5n mice did not reveal significant changes
E2F1 to the tamoxifen-specific variant of the hormone binding do-
in any gluconeogenetic enzymes, including GS andmain of the human estrogen receptor (ER-E2F1 WT) or the equiva-
G6Pase (data not shown). When the C/EBP DNA bindinglent fusion containing a point mutation in the E2F1 DNA binding
activity was assayed using extracts from livers of wild-domain that impairs DNA binding (ER-E2F1 E132) and stably ex-
pressing populations were obtained by puromycin selection. These type and homozygous knockin mice, no consistent dif-
cultures were hormonally induced to differentiate in the presence ferences in the absolute or relative levels of C/EBP com-
of 1 M 4-hydroxy tamoxifen (4OHT) for 8 days. Phase contrast plexes supershifted with anti-C/EBP and anti-C/EBP
micrographs show the accumulation of adipocytes in differentiated antibodies were observed (Figure 5E). The absence of
cultures.
a defect in transcription of known C/EBP-dependent(B) Total cellular RNA (20 g/lane) from two independently trans-
genes, and the presence of normal amounts of C/EBPduced populations for each construct (differentiated as in panel A)
DNA binding activity, indicated that neither the abilitywas subjected to sequential Northern blotting analysis with probes
for the adipocyte-specific aP2 gene and GAPDH. Signals were de- of C/EBP to bind DNA, nor its capacity to activate
tected by PhosphorImaging. target gene expression in vivo were detectably affected
(C) The expression of the ER-E2F1 fusion proteins was analyzed by the introduced mutations. The absence of a liver
in the cell populations from panel (B) prior to induction of differentia- tissue phenotype, the normal liver gene expression pat-tion by Western blotting of equal amounts of total cellular protein
tern, and the presence of normal levels of C/EBP inwith the 12CA5 monoclonal anti-HA antibody. The band correspond-
the livers of mice of all genotypes (Figure 5C) alloweding to the fusion proteins is indicated.
us to investigate the biochemical association between
C/EBP and the E2F complex in vivo, under conditions
where indirect effects due to the introduced mutations
dependent transcription is an essential function of were minimal or absent. We subjected nuclear extracts
C/EBP during adipocyte differentiation. from the livers of mice with the various targeted muta-
tions to gel retardation analysis with an E2F binding site
E2F1 Repression-Deficient C/EBP Alleles Do Not from the dehydrofolate reductase gene (DHFR probe).
Affect Liver Function In Vivo As previously described (Slomiany et al., 2000), we were
In order to analyze the requirement for C/EBP-medi- able to supershift E2F complexes from extracts of liver
ated E2F repression in vivo, we introduced point muta- nuclei from wild-type mice using an anti-C/EBP anti-
body, but not anti-C/EBP antibody (Figure 5F). Thistions into the C/EBP locus through homologous re-
Cell
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Figure 5. Introduction of BRM Alleles into the Mouse Germline
(A) Targeting strategy for knockin of BRM mutations into the C/EBP locus. A BamHI-SalI probe located outside the genomic sequence
included in the targeting constructs was used to detect the correct targeting event by Southern blotting.
(B) Total liver RNA (10 g/lane) from mice with the indicated genotypes (: unmodified C/EBP allele; WT: knockin of wild-type C/EBP
sequence; 1n: knockin of BRM1 mutation etc.) was subjected to sequential Northern blotting with probes for PEPCK and GAPDH; signals
were detected by PhosphorImaging.
(C) 25 g nuclear protein from liver of mice with the indicated genotypes was analyzed by Western blotting with 14AA anti-C/EBP antibody.
The positions of the 42 and 30 kDa forms of C/EBP are indicated. The nonspecific band (marked with an asterisk) acts as a loading control.
(D) Liver sections from knockin mice were stained with hematoxylin-PAS to detect glycogen (stains purple on blue background).
(E) Gel shift analysis of C/EBP binding activity in liver nuclear extracts from mice with the indicated genotypes, using a C/EBP probe from
the aP2 promoter. Appoximately 5 g nuclear protein was used in each lane; competitor (comp: 0.5 pmol cold oligo) antibodies (2 g/lane)
against the , , and  C/EBP isoforms were added as indicated. The positions of the shifted and supershifted C/EBP complexes are indicated.
(F) Gel shift analysis of E2F complexes from liver nuclear extracts were analyzed using a probe from the DHFR promoter. Antibodies were
added as in (E); competitor was added to 5 pmol/lane (comp).
supershift was not observed using nuclear extracts from lar fat pads) than /, WT/WT, or 1n/1n adipocytes
(Figures 6B and 6D). The differentiation of adipose tissue2n/2n or 5n/5n mice, whereas the control WT/WT mice
is thus consistently affected by those C/EBPmutationsand 1n/1n mice behaved as wild-type in this respect.
that impair E2F repression (BRM2, BRM5), and not byThe C/EBP BRM2 and BRM5 mutant proteins thus
the BRM1 allele, which shows wild-type activity in thisfailed to detectably associate with E2F complexes in
respect, and both the amount of adipose tissue and thevivo, indicating that this forms the basis for their de-
differentiation of individual adipocytes was affected. Forcreased ability to repress E2F-mediated transcription.
none of the mutations was any effect observed in the
heterozygous state (data not shown).
E2F Repression-Deficient C/EBP Alleles Cause In the hematopoietic system, C/EBP is highly and
Adipose Hypoplasia and Myeloid Dysplasia specifically expressed in neutrophil granulocytes and is
In Vivo required for the development of this cell type (Zhang et
We next analyzed the effect of the BRM alleles on the al., 1997). We found normal numbers and morphology
differentiation of adipocytes in vivo. We found no differ- of granulocytes from WT/WT and 1n/1n mice, as deter-
ences in the abundance or appearance of adipose tissue mined by flow cytometry and cytospins of bone marrow.
between wild-type, WT/WT, and 1n/1n mice, as illus- In contrast, in 2n/2n and 5n/5n mice, granulocytes were
trated by the size and tissue morphology of gonadal fat few or absent, as shown by the lack of the characteristic
pads from mice with these genotypes (Figures 6A and doughnut-shaped cells in their bone marrow (Figure 7A)
6B and data not shown). In contrast, in both 2n/2n and and peripheral blood (data not shown). This was paral-
5n/5n mice very little or no white adipose tissue was leled by a decrease in or absence of Mac-1/Gr-1 positive
found, as exemplified by the severe hypotrophy of go- bone marrow cells, representing the granulocytic popu-
nadal fat pad tissue in these mice (Figures 6A and 6C). lation, in the 2n/2n and 5n/5n genotypes (Figure 7B). In
The size of the adipocytes found in the fat pads was those cases where granulocyte-like cells were ob-
served, they appeared large and dysplastic (Figure 7A;slightly (ovarian fat pads) or significantly smaller (testicu-
E2F Repression by C/EBP In Vivo
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Figure 6. Effect of BRM Alleles on In Vivo Ad-
ipogenesis
(A) Ovarian fat pads from wild-type (/) and
knockin mice (genotypes indicated). The uteri
(U), ovaries (Ov), and fat pads (FP) are shown.
(B) Sections of fat pad tissue from (A) stained
with hematoxylin-eosin.
(C) Fat pads from testes (T) of /, WT/WT,
and 2n/2n mice.
(D) Sections of fat pad tissue from (C) stained
with hematoxylin-eosin.
2n/2n panel) or apoptotic (5n/5n panel). However, overall was detected in the heterozygous genotypes (not
shown).we did not detect any significant increase in apoptosis
(as measured by Annexin-V and TUNEL staining) in bone
marrow cells isolated from mice harboring E2F repres- Discussion
sion-deficient C/EBP alleles (data not shown). Other
hematopoietic lineages were all present in bone marrow The Role of E2F Repression in C/EBP-Mediated
(erythroid cells), thymus (T cells), and spleen (B cells, T Growth and Differentiation
cells, erythroid cells), and cultures of bone marrow cells The results presented here provide evidence that re-
revealed no defect in macrophage precursor number or pression of the E2F complex is an essential C/EBP
differentiation (Figure 7C and data not shown), indicating function during adipocyte differentiation in vitro, and
that the hematopoietic defect is specific to the granulo- that loss of C/EBP-mediated E2F repression in vivo
cyte lineage. Importantly, in bone marrow the decrease results in dysplasia of neutrophil granulocytes and hypo-
in the granulocyte population was paralleled by an in- plasia of white adipose tissues, two cell types that abso-
crease in Ter119-positive erythroid cells, indicating that lutely require C/EBP for their differentiation.
the myeloid cells did not accumulate at an immature, We find that C/EBP represses the transcriptional ac-
tivation mediated by E2F1/DP1 (Slomiany et al., 2000)antigen-negative stage. Also in this case no phenotype
Cell
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Figure 7. Effect of BRM Alleles on In Vivo Granulopoiesis
(A) Cytospins of bone marrow from wild-type and representative examples of each knockin genotype. Granulocytes appear as doughnut-
shaped cells (closed arrows). In the 2n/2n and 5n/5n panels, dysmorphic granulocyte-like cells are indicated with open arrows.
(B) Flow cytometric analysis of bone marrow cells. Granulocyte populations were identified as staining positive for the Mac-1 (CD11b) and
Gr-1 (Ly-6G) antigens; the percentage of Mac-1/Gr-1 double-positive cells is indicated (R1 gate).
(C) Erythoid cells in bone marrow were identified as staining positive for the Ter119 antigen. The percentage of antigen-positive cells (R2
gate) is indicated.
dependent on C/EBP TE-I, and on non-DNA binding is a crucial pRb function during development. That re-
pression of E2F activity is important during terminal cel-residues of the basic region  helix. This is consistent
with the observation that the p30 form of C/EBP, which lular differentiation has been demonstrated in the myo-
genic lineage and in keratinocytes, where ectopiclacks TE-I, fails to repress E2F activity (Johansen et
al., 2001; M. Schuster and C.N., unpublished data). The expression of E2F1 was found to block differentiation
(Dicker et al., 2000; Wang et al., 1995a). In the hemato-impairment of E2F repression correlates with the de-
crease in growth suppression for all C/EBP alleles in- poietic system, the consequence of uncontrolled E2F
activity in differentiating granulocytic cells has been ad-vestigated, and C/EBP alleles severely affected in
these functions (D1-70, BRM2, BRM5) all fail to induce dressed by Strom et al. (Strom et al., 1998), who found
that ectopic E2F1 expression in the myeloid 32D.3 celladipose conversion of NIH3T3 fibroblasts. Conversely,
we find that ectopic E2F1 activity is able to block the line led to programmed cell death upon induction of
granulocytic differentiation. This could be prevented byC/EBP-dependent differentiation of 3T3-L1 preadipo-
cytes, consistent with the impairment of adipogenesis coexpression of Bcl-2 (but not by G-CSF, the most im-
portant granulocyte survival factor in vivo), in which caseobserved in the presence of C/EBP alleles defective
in E2F repression being a direct consequence of uncon- differentiation was blocked at the metamyelocyte stage.
We observe a strong reduction of neutrophils in the bonetrolled E2F activity. When introduced into the mouse
germline, E2F repression-deficient C/EBP alleles cause marrow of mice harboring E2F repression-deficient
C/EBPalleles, with the few remaining granulocytic cellssevere hypoplasia of white adipose tissues. Together,
these results identify E2F repression as an essential displaying a dysplastic morphology. The presence of
abnormal granulocytes argues against a lack of lineageC/EBP function during adipocyte differentiation, both
in vitro and in vivo. commitment in the mutant mice, and we do not observe
accumulation of immature myeloid cells in young adults,Loss of E2F repression through Rb mutation leads to
ectopic cell proliferation and apoptosis in vivo (Clarke as in the case of C/EBP null mice (Zhang et al., 1997).
Furthermore, we have recently observed progression toet al., 1992; Jacks et al., 1992; Lee et al., 1992). Both of
these effects are abrogated by simultaneous inactiva- granulocyte-type myeloid leukemia in older mice of the
2n/2n genotype (B.P and C.N., unpublished data), sup-tion of either the e2f1 or e2f3 locus (Tsai et al., 1998;
Ziebold et al., 2001), confirming that repression of E2F porting the notion that the mutant C/EBP alleles are
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capable of supporting granulocyte lineage commitment. growth of p21cdki negative cells (Muller et al., 1999). Our
results therefore suggest that the main antiproliferativeOur observations are therefore consistent with pro-
grammed cell death being induced in differentiating function of C/EBP in nonhepatic tissues is direct inhibi-
tion of E2F, whereas p21cdki stabilization and directgranulocytic cells if E2F activity is not adequately con-
trolled by C/EBP. Accumulation of additional mutations E2F repression may both contribute C/EBP-mediated
control of hepatocyte proliferation.with antiapoptotic effect would then lead to uncontrolled
proliferation of immature granulocytic cells and leuke-
mia. The absence of significant levels of apoptotic gran- Mechanism of C/EBP-E2F Antagonism
ulocytic cells in the bone marrow of mice carrying E2F As previously reported (Slomiany et al., 2000), we were
repression-deficient C/EBP alleles may reflect their able to detect C/EBP in E2F complexes from liver nu-
rapid clearance by bone marrow macrophages. In differ- clear extracts of wild-type mice by antibody supershift
entiating granulocytic cells p130, rather than pRb, has analysis. The same was true for the phenotypically nor-
been found to be the critical pocket protein (Bergh et mal WT/WT and 1n/1n genotypes, whereas E2F com-
al., 1999; Mori et al., 1999). Since E2F4 and E2F5 are plexes isolated from mice carrying the BRM2 and BRM5
specifically repressed by p107/p130 (and not by pRb) mutations did not contain detectable C/EBP protein.
this would indicate that, in addition to E2F1, repression Our results thus indicate that the Y285, I294 and R297
of E2F4/5 is critical for proper differentiation of granulo- basic region residues mediate the physical association
cytes. Consistent with this, we find that C/EBP re- between E2F and C/EBP, and that this is instrumental
presses E2F4/DP2-dependent transcription with the to repression. C/EBP represses E2F in the absence of
same molecular requirements as it does E2F1/DP1 (I. functional pRb protein (Johansen et al., 2001; Slomiany
Damgaard and C.N., unpublished). C/EBP therefore et al., 2000). Also, E2F1 with a mutation that decreases
seems to have a broad specificity toward the E2F com- its affinity for pocket proteins is still repressed by
plex, targeting both the E2F1/2/3 and E2F4/5 subfami- C/EBP (T.P. and C.N, unpublished), and deletion of
lies, and repressing both of these to be required during C/EBP TE-II, which is the main pRb interaction domain
granulopoiesis. in C/EBP, has a modest effect on E2F repression and
We cannot exclude that the BRM2 and BRM5 muta- does not detectably affect adipogenesis. The C/EBP
tions affect C/EBP functions other than E2F repression. and pRb pathways of E2F repression therefore appear
However, such distinct functions would not be likely to to work independently. Along with the observation that
be affected by the same subset of C/EBP mutations, pRb is required during adipocyte differentiation in vitro
and microarray-based gene expression analysis has not (Chen et al., 1996), this indicates that pRb and C/EBP
revealed any effects of the BRM alleles on the expres- act in parallel to repress E2F, both being required for
sion of known C/EBP target genes (including GS, se- efficient repression and differentiation to occur, whereas
rum albumin, G6Pase, or PEPCK) in vivo, nor do we find we do not observe a strong correlation between
any DNA binding defect in C/EBP molecules isolated C/EBP-pRb interaction and adipogenesis.
from mice homozygous for the various C/EBP alleles. In summary, our results provide direct genetic evi-
We therefore believe that the effects we observe in the dence that repression of the E2F complex is an essential
2n/2n and 5n/5n genotypes are mainly attributable to in vivo function of the C/EBP transcription factor during
their defect in E2F repression. normal development. This provides an example of a
lineage-instructive transcription factor mediating termi-
Tissue-Specific Requirement for E2F Repression nal differentiation through direct interference with the
by C/EBP cell cycle machinery. Significantly, the most common
We find that the requirement for C/EBP-mediated E2F C/EBP mutation observed in AML patients leads to
repression is tissue specific, in that no abnormalities overexpression of the p30 form of C/EBP (Pabst et al.,
were observed in livers from 2n/2n or 5n/5n mice. Con- 2001), which does not repress E2F. This, along with the
sistent with this, DNA microarray analysis revealed no observed leukemic progression of 2n/2n mice, suggests
increase in expression of PCNA, cyclin A, cyclin E, that loss of C/EBP-mediated cell cycle arrest is instru-
DHFR, or Ki-67 mRNA in livers from 2n/2n or 5n/5n mice mental in the development of AML. That C/EBP and
(B.P. and C.N, unpublished data). This contrasts with the prototypic pRb tumor suppressor both target the
the findings from C/EBP null animals, where hyperpro- E2F complex in vivo underscores the importance of the
liferation (Flodby et al., 1996) associated with upregula- E2F protein family in deregulation of cellular proliferation
tion of PCNA and cyclin A was observed (Timchenko et and differentiation during malignant cellular transforma-
al., 1999a), and suggests that pathways other than E2F tion, and raises the possibility that interference with
repression are affected in the complete absence of C/EBP-mediated E2F repression plays a role in neopla-
C/EBP protein. In hepatocytes C/EBP has been found sia of other tissues whose terminal differentiation is con-
to increase the expression of p21cdki (Park et al., 2000; trolled by C/EBP.
Timchenko et al., 1996, 1997), and ectopic p21cdki ex-
pression is sufficient to block hepatocyte proliferation Experimental Procedures
in response to liver damage (Wu et al., 1996). However,
DNA Constructsregulation of p21cdki expression or stability by C/EBP
Rat C/EBP deletion mutants have been previously described (Ner-has not been generally observed in nonhepatic cell types
lov and Ziff, 1994). The basic region point mutants (BRM-1:
(Slomiany et al., 2000). Furthermore, no proliferative de- V287A,E290A; BRM-2: I294A,R297A; BRM-3: D301A,K304A; BRM-5:
fect has been described in p21cdki knockout mice (Deng Y285A) were introduced by overlapping PCR and confirmed by DNA
sequencing. All C/EBP derivatives were introduced into pBabe-et al., 1995), and C/EBP is capable of arresting the
Cell
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Puro (Morgenstern and Land, 1990) for retroviral infection and pcDNAI-based T7 expression vectors, the Promega TNT T7 coupled
transcription/translation system and 35S-Promix (Amersham). BoundpcDNAI (Invitrogen) for transient transfection as BamHI-EcoRI frag-
ments. For generation of C/EBP-EGFP fusion constructs, the 35S-labeled proteins were resolved by SDS-PAGE and quantified on
a Fuji BAS2500 PhosphorImager.C/EBP and EGFP were fused by introducing XbaI sites at the 3
end of the C/EBP coding sequence and 5 end of the EGFP coding
sequence by PCR, and cloning them into the pBabePuro BamHI and
Generation of C/EBP Knockin MiceEcoRI sites as BamHI-XbaI and XbaI-EcoRI fragments, respectively.
E14.1 embryonic stem cells (obtained from Dr. Ru¨diger Klein, EMBL,The CMV-E2F1, CMV-DP1, and pCMVneoBam expression vectors,
Heidelberg) were maintained in Knock-Out DMEM supplementedthe pE2Fx6-TATA-LUC reporter, and the pBabePuro-HA-ERTM-E2F1
with 15% ES Serum Replacement and LIF (Life Technologies). ESretroviral constructs (Vigo et al., 1999) were generously provided by
cells were transfected by electroporation and 192 resistant clonesDr. Kristian Helin, European Institute for Oncology, Milan, Italy.
for each construct were selected and expanded. Southern blot anal-
ysis of HindIII-digested genomic DNA, using a 1.2 kb BamHI-SalI
Targeting Constructs probe located outside the targeting construct, identified approxi-
A SalI-XbaI fragment containing a loxP flanked PGK-neo-polyA cas- mately 10% of the selected clones as correctly targeted by the
sette was excised from pFM54 (kindly provided by Dr. Flavio Maina, appearance of a 9.7 kb fragment compared to the 7.5 kb fragment
EMBL, Heidelberg) and inserted into the XhoI-XbaI sites of pCMV- present in the nontargeted allele. Two clones derived from each
C/EBP (Nerlov and Ziff, 1994), which encodes full length rat construct were injected into C57BL/6 blastocysts and the resulting
C/EBP. The XbaI site was destroyed by insertion of a SalI linker. chimeras were bred for germline transmission. Strains were main-
From this plasmid a 2.8 kb HindIII-SalI fragment (containing the tained on a 50% C57BL/6; 50% 129/Ola background.
C/EBP coding sequence and the neo cassette) was excised. A
genomic murine C/EBP clone (an 11 kb BamHI fragment in pBlue-
script (Wang et al., 1995b) obtained from Gretchen Darlington, Bay- Histology of Knockin Mice
lor College of Medicine, Houston, Texas) was collapsed by HincII Knockin mice were analyzed at 8 weeks of age. Tissues were re-
cleavage and religation thereby converting the HincII site at the 3 moved, and either fixed in 4% paraformaldehyde/PBS overnight,
end of the C/EBP coding sequence to a SalI site. A BamHI-SalI paraffin embedded, sectioned at 8 m and stained with hematoxy-
fragment containing C/EBP 3 flanking sequences was ligated to lin-eosin (for morphology) or hematoxylin-periodic acid Schiff (PAS;
the above HindIII-SalI fragment and inserted into HindIII/BamHI- to detect liver glycogen), used for RNA preparation (Chomczynski
digested pUC19. A 6.5 kb MluI-BamHI fragment from this construct and Sacchi, 1987) or for preparation of nuclear extracts (prepared
(containing the 3 half of the C/EBP ORF, neo cassette and the 3 according to Timchenko et al., 1999b).
flanking sequence) was ligated to a 4.9 kb SalI-MluI fragment from
the genomic clone (containing 5 flanking sequence and the 5 half
Flow Cytometryof the C/EBP ORF) and inserted into SalI/BamHI digested pUC19.
Bone marrow was obtained by flushing of femurs with DMEM sup-This generated the wild-type knockin targeting construct (pWTKI);
plemented with 10% FCS, antibiotics and K-HEPES (pH 7.5) to apBRM1KI, pBRM2KI, and pBRM5KI were constructed in the same
final concentration of 20 mM. Methanol fixed cytospins were stainedmanner. The resulting constructs encode hybrids between mouse
with methylene blue/eosin. Flow cytometry was performed by stain-(5 end) and rat (3 end) C/EBP.
ing with Mac-1-FITC, Ter119-PE, Gr-1-APC or corresponding iso-
type control antibodies (Pharmingen) and analysis on a FACSCalibur
Tissue Culture, Retroviral Infection, and Transfection
flow cytometer (Becton Dickinson).
NIH3T3 cells (a kind gift from Dr. Karsten Kristiansen, Odense Uni-
versity, Odense, Denmark) and Phoenix-E ecotropic retroviral pack-
aging cells (generously provided by Dr. G. Nolan, Stanford Univer- Electrophoretic Mobility Shift Assay
sity, San Francisco, USA) were grown in DMEM containing 10% Liver nuclear extracts were used for EMSA experiments using a
fetal calf serum and antibiotics (Life Technologies). Retroviral stocks C/EBP probe derived from the aP2 promoter (Nerlov and Ziff, 1994)
were obtained by transiently transfecting Phoenix-E cells with pBabe- and an E2F probe derived from the DHFR promoter (Slomiany et
Puro-based proviral constructs using calcium phosphate coprecipi- al., 2000). 32P-labeled probe in 10 l H2O was added to the nuclear
tation. 48 hr after transfection culture supernatants were harvested, extracts (3–5 g nuclear protein), preincubated for 20 min on ice in
filtered through 0.45 m sterile filters (Millipore), and used to infect 10 l 20 mM HEPES (pH 7.9), 100 mM KCl, 5 mM MgCl2, 0.05 mM
subconfluent (30%) layers of NIH3T3 cells overnight in the presence ZnCl2, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT, 0.1 mg/ml poly-
of 5 g/ml polybrene (Sigma). After infection cells were grown in [d(I-C)], 1 mg/ml BSA, 0.05% NP-40, 20% glycerol, and incubation
the presence of 1 g/ml puromycin (Sigma) for 2 weeks to allow was continued for 30 min at room temperature. When cold competi-
differentiation to occur. Quantitative Oil Red O staining was done tor (50- to 250-fold excess) or antibodies (14AA anti-C/EBP (sc-
as described (Ramirez-Zacarias et al., 1992). For assay of growth 61X), C19 anti-C/EBP (sc-150X) or C-22 anti-C/EBP (sc-151X); all
inhibition virally infected cells were split 3–4 times over a 2 week from Santa Cruz Biotechnology) were used they were added to-
period to maintain subconfluence, after which cells were harvested gether with the labeled probes. Samples were resolved on a 6%
for FACS analysis. 3T3-L1 cells (obtained from the ATCC) were polyacrylamide gel in 0.5	 TBE buffer.
transduced as described above, and were grown and differentiated
as previously described (Cao et al., 1991). 1M 4-hydroxy tamoxifen
RNA Preparation and Northern Blottingwas included in the medium used to differentiate the cells. Q2bn
Total RNA was prepared according to Chromczynski and Sacchifibroblasts were cultured and transiently transfected and assayed
(Chomczynski and Sacchi, 1987). Northern blotting was performedfor reporter gene expression as previously described (Querfurth et
using Biodyne B membranes (Life Technologies) and the followingal., 2000).
probes: aP2, PEPCK (obtained from Dr. Karsten Kristiansen, Odense
University, Denmark), and GAPDH (Hanauer and Mandel, 1984).Western Blotting
Probes were labeled with 32P-dCTP (Amersham-Pharmacia) usingWestern blotting of C/EBP was performed as described (Nerlov
random priming (RadPrime; Life Technologies). Hybridization wasand Ziff, 1994). Primary antibodies were C103 rabbit anti-C/EBP
done in Quickhyb (Stratagene) and stringent washes in 0.2	 SSC,antiserum, rabbit anti-C/EBP (sc-61; Santa Cruz Biotechnology),
0.1% SDS at 65
C.12CA5 mouse monoclonal anti-HA tag antibody (Sigma).
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